Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 06, 2026, 18:56 UTC
  • 7
  • 1 comments

Why Is Fortnite Not Working? Troubleshooting Steps To Try

Market reaction Comment Full text

Profound Medical Corp (PROF)

  • SEC News
  • Jan. 06, 2026, 18:39 UTC
  • 5
  • 1 comments

(85% Positive) PROFOUND MEDICAL CORP. (PROF) Provides Update on advancement for prostate care

Comment Full text

Zymeworks Inc (ZYME)

  • Business News
  • Jan. 06, 2026, 18:34 UTC
  • 9
  • 1 comments

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit

Market reaction Comment Full text

Qualigen Therapeutics Inc. (QLGN)

  • SEC News
  • Jan. 06, 2026, 18:32 UTC
  • 5
  • 1 comments

(70% Positive) AIxCrypto Holdings, Inc. (QLGN) Announces Business Combination

Comment Full text

Jazz Pharmaceuticals plc (JAZZ)

  • Business News
  • Jan. 06, 2026, 18:32 UTC
  • 8
  • 1 comments

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall Survival Benefit

Market reaction Comment Full text

Alvotech (ALVOW)

  • Event
  • Jan. 06, 2026, 18:07 UTC
  • 12
  • 1 comments

Alvotech (ALVOW) Files Form 6-K

Comment Full text

Smart for Life, Inc. (SMFL)

  • Business News
  • Jan. 06, 2026, 17:30 UTC
  • 8
  • 1 comments

Inside the Smart India Hackathon: Innovation, Impact, and the Power of Youth in Problem-Solving

Market reaction Comment Full text

GENFIT S.A. (GNFT)

  • Business News
  • Jan. 06, 2026, 17:13 UTC
  • 9
  • 1 comments

GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N

Market reaction Comment Full text

Corcept Therapeutics Incorporated (CORT)

  • SEC News
  • Jan. 06, 2026, 17:04 UTC
  • 5
  • 1 comments

📋 Guyer William (Officer) plans to sell 20K shares of CORCEPT THERAPEUTICS INC (at $34.95 each, total $699K) Filed: Jan 06, 2026 | ID: 000003

Comment Full text

Corcept Therapeutics Incorporated (CORT)

  • Business News
  • Jan. 06, 2026, 17:01 UTC
  • 7
  • 1 comments

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman

Market reaction Comment Full text

Lantheus Holdings Inc. (LNTH)

  • SEC News
  • Jan. 06, 2026, 16:43 UTC
  • 5
  • 1 comments

📋 Blanchfield Paul (Ex-Officer) plans to sell 7K shares of Lantheus Holdings, Inc. (at $69.53 each, total $502K) Filed: Jan 06, 2026 | ID: 000134

Comment Full text

HALEON PLC (HLN)

  • Event
  • Jan. 06, 2026, 16:38 UTC
  • 14
  • 1 comments

HALEON PLC (HLN) Files Form 6-K

Comment Full text

Stryker Corporation (SYK)

  • Business News
  • Jan. 06, 2026, 16:34 UTC
  • 5
  • 1 comments

VB Spine finalise le rachat à Stryker du site de fabrication de Cestas

Market reaction Comment Full text

Vertex Pharmaceuticals (VRTX)

  • SEC News
  • Jan. 06, 2026, 16:16 UTC
  • 3
  • 1 comments

📋 WAGNER CHARLES F JR (Officer) plans to sell 10K shares of VERTEX PHARMACEUTICALS INC / MA (at $461.00 each, total $4.4M) Filed: Jan 06, 2026 | ID: 000131

Comment Full text

Galectin Therapeutics Inc. (GALT)

  • SEC News
  • Jan. 06, 2026, 16:10 UTC
  • 3
  • 1 comments

📋 Shlevin Harold H. (Director) plans to sell 442K shares of GALECTIN THERAPEUTICS INCORPORATED (at $4.16 each, total $1.8M) Filed: Jan 06, 2026 | ID: 000797

Comment Full text
  • Previous
  • 746
  • 747
  • 748
  • 749
  • 750
  • Next

Search

News categories

  • Technical Exchange News(10969)
  • Event(2441)
  • SEC News(193597)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125910)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin